Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda

Harriet Nakigozi,Rawlance Ndejjo,William Bazeyo,Annet Nabaggala,Caroline Achola,Moses Iga,Simeon Kalyesubula,Ben Kanamwangi,Gerald Mutungi,Charles Batte,David Mukunya,Lawrence Sserwanga,Godfrey Gemageine,Charles Akiya Oyoo,Susan Nabadda
DOI: https://doi.org/10.1186/s12885-024-11928-0
IF: 4.638
2024-02-23
BMC Cancer
Abstract:Women living with HIV are at risk for cervical dysplasia and cancer worldwide. In 2015, the World Health Organization (WHO) recommended that testing for high-risk HPV (hrHPV) infection be incorporated into cervical cancer screening programs using molecular nucleic acid tests (NATs) but this has not previously been done in Uganda. The country's coverage for Human Papilloma Virus (HPV) screening remains low at less than 10% for women aged 25–49 years. This study determined the genital prevalence of hrHPV infection and the associated factors among women living with HIV in Uganda.
oncology
What problem does this paper attempt to address?